Teva Pharmaceutical Industries (TEVA) Q1 Earnings: How Key Metrics Compare to Wall Street Estimates

For the quarter ended March 2024, Teva Pharmaceutical Industries Ltd. (TEVA) reported revenue of $3.82 billion, up 4.3% over the same period last year. EPS came in at $0.48, compared to $0.40 in the year-ago quarter.The reported revenue compares to the Zacks Consensus Estimate of $3.7 billion, representing a surprise of +3.25%. The company delivered an EPS surprise of -5.88%, with the consensus EPS estimate being $0.51.While investors closely watch year-over-year changes in headline numbers -- revenue and e ...